Copy to clipboard 
Today we released our public and private orthopedic company sales estimates along with Joint Replacement, Spine, Trauma, Sports Medicine, Orthobiologics and Enabling Technology market projections in the latest installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®.
The eight largest orthopedic companies—Stryker, DePuy Synthes, Zimmer Biomet, Smith+Nephew, Medtronic, Arthrex, NuVasive and Globus Medical—each have revenue exceeding $1 billion annually, and together control 66% of the market. The number of top companies will soon drop to seven after Globus Medical completes its pending acquisition of NuVasive later this year.
In 2021, Stryker reclaimed the No. 1 position in orthopedics due to its acquisition of Wright Medical. Globus Medical’s acquisition of NuVasive and Orthofix’s acquisition of SeaSpine emphasize the continued consolidation and changing dynamics of the major players.
We estimate that the orthopedic market has more than 1,000 active companies, which we categorize into five tiers based on global annual revenue:
- Over $1 billion
- Between $400 million and $999 million
- Between $200 million and $399 million
- Between $100 million and $199 million
- All other companies below $100 million
Only 46 of the 1,000+ companies generated more than $100 million in orthopedic revenue in 2022 and together they account for 84% of all orthopedic sales worldwide. Their revenue data is detailed in the report. Segment-specific chapters on the Joint Replacement, Spine, Trauma, Sports Medicine, Orthobiologics and Enabling Technology markets provide insight into company sales, market dynamics and business critical trends.
Our proprietary revenue estimates and four-year market forecasts are vital and popular components of the report. Our Executive-level Members use the report for various purposes. These Members are primarily C-level executives at orthopedic device companies who use the intel to validate and drive internal decisions, forecast market and company growth, analyze the competition and identify acquisition targets. A contingent of orthopedic supplier executives use the report to stay current with the pressing issues facing their OEM customers.
Our Elite-level Members require historical performance in addition to current data to bolster their internal models, predictions and plans. In this way, the annual report is a great starting point to explore our exclusive revenue models. Every report and data file that we create is available to Elite Members.
Already an ORTHOWORLD Member? Download the report from the My ORTHOWORLD section of your account.
Considering Membership? Evaluate the plans here, here and here.
Today we released our public and private orthopedic company sales estimates along with Joint Replacement, Spine, Trauma, Sports Medicine, Orthobiologics and Enabling Technology market projections in the latest installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®.
The eight largest orthopedic companies—Stryker, DePuy Synthes, Zimmer Biomet,...
Today we released our public and private orthopedic company sales estimates along with Joint Replacement, Spine, Trauma, Sports Medicine, Orthobiologics and Enabling Technology market projections in the latest installment of THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT®.
The eight largest orthopedic companies—Stryker, DePuy Synthes, Zimmer Biomet, Smith+Nephew, Medtronic, Arthrex, NuVasive and Globus Medical—each have revenue exceeding $1 billion annually, and together control 66% of the market. The number of top companies will soon drop to seven after Globus Medical completes its pending acquisition of NuVasive later this year.
In 2021, Stryker reclaimed the No. 1 position in orthopedics due to its acquisition of Wright Medical. Globus Medical’s acquisition of NuVasive and Orthofix’s acquisition of SeaSpine emphasize the continued consolidation and changing dynamics of the major players.
We estimate that the orthopedic market has more than 1,000 active companies, which we categorize into five tiers based on global annual revenue:
- Over $1 billion
- Between $400 million and $999 million
- Between $200 million and $399 million
- Between $100 million and $199 million
- All other companies below $100 million
Only 46 of the 1,000+ companies generated more than $100 million in orthopedic revenue in 2022 and together they account for 84% of all orthopedic sales worldwide. Their revenue data is detailed in the report. Segment-specific chapters on the Joint Replacement, Spine, Trauma, Sports Medicine, Orthobiologics and Enabling Technology markets provide insight into company sales, market dynamics and business critical trends.
Our proprietary revenue estimates and four-year market forecasts are vital and popular components of the report. Our Executive-level Members use the report for various purposes. These Members are primarily C-level executives at orthopedic device companies who use the intel to validate and drive internal decisions, forecast market and company growth, analyze the competition and identify acquisition targets. A contingent of orthopedic supplier executives use the report to stay current with the pressing issues facing their OEM customers.
Our Elite-level Members require historical performance in addition to current data to bolster their internal models, predictions and plans. In this way, the annual report is a great starting point to explore our exclusive revenue models. Every report and data file that we create is available to Elite Members.
Already an ORTHOWORLD Member? Download the report from the My ORTHOWORLD section of your account.
Considering Membership? Evaluate the plans here, here and here.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
